Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

Presentation TCT 2024

TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR)

Presenter: Allan Schwartz

October 30, 2024

Presentation TCT 2024

Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED)

Presenter: Mark Dweck

October 30, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

Presentation TCT 2024

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Presenter: Mark Dweck

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

Presenter: Philippe Genereux

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Presentation TCT 2024

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Presenter: Mark Dweck

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

Presenter: Philippe Genereux

October 28, 2024

Presentation TCT 2024

TCT 92: Early Transcatheter or Surgical Aortic Valve Replacement Versus Conservative Management in Asymptomatic Patients With Severe Aortic Stenosis: A Systematic Review and Meta-analysis

Presenter: Avinash Nankani

October 27, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

Presentation TCT 2023

TCT 775: A Machine Learning Based Model Predicts Death in Patients with Severe Asymptomatic Aortic Stenosis

Presenter: APURVA BHARUCHA

October 26, 2023

Presentation TCT 2023

TCT 331: Cardiac Damage Staging Predicts Outcomes in Symptomatic and Asymptomatic Aortic Valve Stenosis after Aortic Valve Replacement: Meta-Analysis of Reconstructed Time-to-Event Data

Presenter: Omar Abdelfattah

October 26, 2023

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

Presentation TCT 2022

Case Presentation: A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis

Presenter: Tom Cahill

September 18, 2022

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis: Evidence Updates

Presenter: Philippe Genereux

October 16, 2020

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

Presentation TCT 2018

Putting It All Together: A Proposed New Staging Classification for Patients with Aortic Stenosis

Presenter: Philippe Genereux

September 22, 2018

Advertisement

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR)

Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED)

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

TCT 92: Early Transcatheter or Surgical Aortic Valve Replacement Versus Conservative Management in Asymptomatic Patients With Severe Aortic Stenosis: A Systematic Review and Meta-analysis

What’s Going to Be Big at TCT 2024?

TCT 775: A Machine Learning Based Model Predicts Death in Patients with Severe Asymptomatic Aortic Stenosis

TCT 331: Cardiac Damage Staging Predicts Outcomes in Symptomatic and Asymptomatic Aortic Valve Stenosis after Aortic Valve Replacement: Meta-Analysis of Reconstructed Time-to-Event Data

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Case Presentation: A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis

TAVR in Low Surgical Risk Patients - Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis: Evidence Updates

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Putting It All Together: A Proposed New Staging Classification for Patients with Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content